Table 2.

Treatment dosage, adverse events, and symptom severity over time

	Before treatment			3 months			6 months
Dosage
Prescribed, mean±SD, mg				38.33	±	5.07	38.61	±	4.87
Taken, mean±SD, mg				36.53	±	6.64	37.78	±	5.40
Adverse events, n, %				21		58.3%	6		16.7%
Change in appetite				2		5.6%	0		0%
Weight loss/gain				2		5.6%	1		2.7%
Abdominal pain				3		8.3%	2		5.6%
Diarrhea				4		11.1%	0		0%
Constipation				1		2.8%	0		0%
Dry mouth				2		5.6%	1		2.8%
Restlessness				0		0%	0		0%
Drowsiness				4		11.1%	1		2.8%
Insomnia				1		2.8%	0		0%
Headache				3		8.3%	0		0%
Vertigo				3		8.3%	0		0%
Sweating				2		5.6%	0		0%
Palpitations				1		2.8%	0		0%
Tremor				0		0%	0		0%
Sexual dysfunction				0		0%	0		0%
Other				15		42%	3		8.3%
CAPS total, mean±SD	71.80	±	14.29	60.53	±	24.60	60.08	±	25.86
Intrusion	20.93	±	4.41	17.06	±	7.34	16.89	±	7.79
Avoidance	28.16	±	8.08	24.19	±	11.96	23.36	±	12.31
Hyperarousal	23.91	±	3.84	19.28	±	6.80	19.83	±	6.91
BDI, mean±SD	25.71	±	10.71	21.52	±	11.84	21.86	±	13.53